ACC/AHA Heart Failure Staging

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰۰ • واحد: %

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
hf stage
—stage
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Stage A0–0
  • Stage B1–1
  • Stage C2–2
  • Stage D3–3
Direct Clinical Answer

The ACC/AHA Heart Failure Staging calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include risk factors. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Describes heart failure stages and provides stage-specific therapy recommendations, based on ACC/AHA/HFSA guidelines

Clinical Indication

The ACC/AHA Heart Failure Staging is indicated for bedside clinical practice to support Describes heart failure stages and provides stage-specific therapy recommendations, based on ACC/AHA/HFSA guidelines. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Based on ACC/AHA/HFSA 2022 guidelines.

Formula & Variables:

Classification based on presence of risk factors, structural disease, symptoms, and severity

Input Parameters

NameTypeRequiredDescription
risk_factorsstringYesPresence of risk factors for heart failure
structural_diseasestringYesEvidence of structural heart disease or elevated biomarkers
current_symptomsstringYesCurrent or previous symptoms of heart failure
advanced_symptomsstringYesSevere symptoms refractory to optimized treatment
hospitalization_frequencystringYesRecurrent hospitalizations for heart failure
ejection_fractionfloatNoLeft ventricular ejection fraction (%)(%)

Score Interpretation & Guidance

RangeStageDescription
0–0Stage AAt risk for heart failure
1–1Stage BPre-heart failure
2–2Stage CSymptomatic heart failure
3–3Stage DAdvanced heart failure

Evidence-Based References (EBM)

  • Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032.
  • Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation. 2005;112(12):e154-235.

Related calculators